NASDAQ:GTXI GTX (GTXI) Stock Price, News & Analysis → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free GTXI Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$8.54▼$8.9550-Day Range$1.20▼$7.2052-Week Range$0.74▼$25.60Volume4,082 shsAverage Volume390,540 shsMarket Capitalization$208.27 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesSocial MediaStock AnalysisCompetitorsHeadlinesSocial Media Get GTX alerts: Email Address Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… About GTX Stock (NASDAQ:GTXI)GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of medicines for the treatment of stress urinary incontinence (SUI) and prostate cancer. It develops selective androgen receptor modulators (SARMs) for the treatment of breast cancer, SUI, and Duchenne muscular dystrophy; and selective androgen receptor degraders to treat progressive castration-resistant prostate cancer. The company's SARM product candidate is the enobosarm GTx-024, a Phase II proof-of-concept clinical trial for patients with androgen receptor (AR) positive triple-negative breast cancer; and estrogen receptor positive and AR positive advanced breast cancer, as well as postmenopausal women with SUI. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.Read More Ad InvestorPlaceBible Shocker: Have You Seen Elon Musk’s Miracle?Breaking News: Elon Musk Invents New Type of A.I. (Shocking) Elon Musk is about to shock the world again with this new type of A.I.… Minting new millionaires in the process.Click here for the full story… GTXI Stock News HeadlinesMay 18 at 6:41 PM | msn.comGhost of Tsushima is a great PC port with one big problemMay 17 at 11:00 PM | msn.comA HOT ROD Legend's 1932 Ford Roadster and How It Embodies the MagazineMay 14, 2024 | msn.comTeva and FP Movement Join Forces on Stylish New Collection for Outdoor EnthusiastsMay 14, 2024 | yahoo.comTeva x FP Movement Limited-Edition Collection Gallery [PHOTOS]May 11, 2024 | msn.comVW Realizes People Want the GTI Name, not ‘GTX’ on Electric CarsMay 10, 2024 | msn.comThe all-new Volkswagen ID.3 GTX Interior Design in Kings Red MetallicMay 10, 2024 | msn.com7 top GPUs of all timeMay 7, 2024 | investorplace.comCGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q1 2024May 6, 2024 | cnn.comFinally, a cushy ultralight hiking boot: Altra Timp Hiker GTX reviewMay 2, 2024 | finance.yahoo.comUltragenyx Pharmaceutical Inc (RARE) Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows ...May 1, 2024 | msn.comCome on a Photo Tour of Car Culture in JapanMay 1, 2024 | msn.com'K-pass' begins operation, offering transport discounts nationwideMay 1, 2024 | msn.comMost-Anticipated Video Games Releasing In May 2024: ‘Ghost Of Tsushima’, ‘F1 24’ And MoreApril 30, 2024 | yahoo.com64 Gifts for New Dads That He Will LoveApril 30, 2024 | msn.com8 Best Waterproof Running Shoes, According to ExpertsApril 28, 2024 | markets.businessinsider.comFrom MacBook Air to HP Laptops: Hire MacBook Pro From Kolkata's Leading Laptop RentalApril 26, 2024 | markets.businessinsider.comBuy Rating for Garrett Motion: Temporary Downturn but Positive Long-Term OutlookApril 25, 2024 | investorplace.comGTX Stock Earnings: Garrett Motion Beats EPS, Misses Revenue for Q1 2024April 22, 2024 | msn.comThe Witcher 3: Wild Hunt Mods Now Available on SteamApril 22, 2024 | msn.com5 Of The Best Affordable Graphics Cards You Can Get In 2024April 22, 2024 | msn.comOriginal Joe Dirt Dodge Charger Daytona Movie Car Sells for $330,000April 18, 2024 | markets.businessinsider.comBuy Rating on Ultragenyx Pharmaceutical Bolstered by GTX-102’s Promise and Positive Valuation OutlookApril 17, 2024 | msn.comExclusive: Former ministry official leads GTX-A rail project with hefty compensationApril 17, 2024 | msn.comSony’s new PlayStation PC overlay and shared Trophies arrive with Ghost of TsushimaApril 17, 2024 | bizjournals.comUS Farathane, a supplier to Tesla and other automakers, sees Austin metro as a key part of its growthSee More Headlines Receive GTXI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2018Today5/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical Preparations Sub-IndustryBiotechnology Current SymbolNASDAQ:GTXI CUSIP40052B10 CIK1260990 Webwww.gtxinc.com Phone901-523-9700FaxN/AEmployees21Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-38,420,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-104.19% Return on Assets-86.42% Debt Debt-to-Equity RatioN/A Current Ratio12.39 Quick Ratio12.39 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.09 per share Price / Book7.94Miscellaneous Outstanding Shares24,050,000Free FloatN/AMarket Cap$208.27 million OptionableNot Optionable Beta2.22 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesDr. Robert James Wills B.S. (Age 65)M.S., Ph.D., Exec. Chairman Mr. Marc S. Hanover (Age 56)Co-Founder, CEO & Director Mr. Henry P. Doggrell (Age 70)VP, Chief Legal Officer & Sec. Mr. Jason T. Shackelford (Age 44)VP of Fin. & Accounting, Principal Financial & Accounting Officer and Corp. Controller Dr. Diane C. Young (Age 62)VP & Chief Medical Officer Key CompetitorsMerrimack PharmaceuticalsNASDAQ:MACKRigel PharmaceuticalsNASDAQ:RIGLEmergent BioSolutionsNYSE:EBSRegulus TherapeuticsNASDAQ:RGLSXOMANASDAQ:XOMAView All Competitors GTXI Stock Analysis - Frequently Asked Questions How were GTX's earnings last quarter? GTx, Inc. (NASDAQ:GTXI) announced its quarterly earnings data on Thursday, November, 15th. The biopharmaceutical company reported ($0.39) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.09. What other stocks do shareholders of GTX own? Based on aggregate information from My MarketBeat watchlists, some companies that other GTX investors own include Corbus Pharmaceuticals (CRBP), Synergy Pharmaceuticals (SGYP), Novavax (NVAX), Inovio Pharmaceuticals (INO), Verastem (VSTM), Catalyst Pharmaceuticals (CPRX), MEI Pharma (MEIP), Progenics Pharmaceuticals (PGNX), Rigel Pharmaceuticals (RIGL) and Amarin (AMRN). This page (NASDAQ:GTXI) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GTx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.